Denmark’s Commit Biologics secures €54 million Seed funding to advance cancer and autoimmune therapies
Copenhagen-based BioTech startup Commit Biologics has raised €54 million ($60 million) in Seed funding to develop new treatments for cancer and autoimmune diseases. The investment will help the Danish company bring its first drug candidate closer to clinical trials. The final close was led by Ackermans & van Haaren, with participation from additional new investors […] The post Denmark’s Commit…
We haven't written up this one. EU-Startups has the full story — the link below goes straight to it.